10x Genomics (NASDAQ:TXG) Downgraded by Leerink Partners to Market Perform
Leerink Partners cut shares of 10x Genomics (NASDAQ:TXG – Free Report) from an outperform rating to a market perform rating in a report released on Thursday morning, MarketBeat Ratings reports. The firm currently has $12.00 price target on the stock, down from their prior price target of $25.00. TXG has been the subject of several […]
Leerink Partners cut shares of 10x Genomics (NASDAQ:TXG – Free Report) from an outperform rating to a market perform rating in a report released on Thursday morning, MarketBeat Ratings reports. The firm currently has $12.00 price target on the stock, down from their prior price target of $25.00. TXG has been the subject of several […]
